These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Impact of renal denervation on renal content of GLUT1, albuminuria and urinary TGF-beta1 in streptozotocin-induced diabetic rats. D'Agord Schaan B; Lacchini S; Bertoluci MC; Irigoyen MC; Machado UF; Schmid H Auton Neurosci; 2003 Mar; 104(2):88-94. PubMed ID: 12648610 [TBL] [Abstract][Full Text] [Related]
4. Preservation of kidney function with combined inhibition of NADPH oxidase and angiotensin-converting enzyme in diabetic nephropathy. Thallas-Bonke V; Coughlan MT; Bach LA; Cooper ME; Forbes JM Am J Nephrol; 2010; 32(1):73-82. PubMed ID: 20551625 [TBL] [Abstract][Full Text] [Related]
5. Comparative antihypertensive and renoprotective effects of telmisartan and lisinopril after long-term treatment in hypertensive diabetic rats. Wienen W; Richard S; Champeroux P; Audeval-Gerard C J Renin Angiotensin Aldosterone Syst; 2001 Mar; 2(1):31-6. PubMed ID: 11881063 [TBL] [Abstract][Full Text] [Related]
6. [Renal tissue angiotensins during converting enzyme inhibition of angiotensin I in spontaneously hypertensive rat]. Ingert C; Grima M; Michel B; Barthelmebs M; Imbs JL Arch Mal Coeur Vaiss; 1997 Aug; 90(8):1135-41. PubMed ID: 9404423 [TBL] [Abstract][Full Text] [Related]
7. Kinins are involved in the antiproteinuric effect of angiotensin-converting enzyme inhibition in experimental diabetic nephropathy. Tschöpe C; Seidl U; Reinecke A; Riester U; Graf K; Schultheiss HP; Hilgenfeldt U; Unger T Int Immunopharmacol; 2003 Mar; 3(3):335-44. PubMed ID: 12639811 [TBL] [Abstract][Full Text] [Related]
8. Increased urinary TGF-beta1 and cortical renal GLUT1 and GLUT2 levels: additive effects of hypertension and diabetes. Schaan BD; Irigoyen MC; Bertoluci MC; Lima NG; Passaglia J; Hermes E; Oliveira FR; Okamoto M; Machado UF Nephron Physiol; 2005; 100(3):p43-50. PubMed ID: 15855808 [TBL] [Abstract][Full Text] [Related]
9. Cardiovascular hypertrophy in diabetic spontaneously hypertensive rats: optimizing blockade of the renin-angiotensin system. Lassila M; Davis BJ; Allen TJ; Burrell LM; Cooper ME; Cao Z Clin Sci (Lond); 2003 Apr; 104(4):341-7. PubMed ID: 12653675 [TBL] [Abstract][Full Text] [Related]
10. Chronic kidney disease: cardiac and renal angiotensin-converting enzyme (ACE) 2 expression in rats after subtotal nephrectomy and the effect of ACE inhibition. Burrell LM; Burchill L; Dean RG; Griggs K; Patel SK; Velkoska E Exp Physiol; 2012 Apr; 97(4):477-85. PubMed ID: 22198016 [TBL] [Abstract][Full Text] [Related]
11. Increased renal GLUT1 abundance and urinary TGF-beta 1 in streptozotocin-induced diabetic rats: implications for the development of nephropathy complicating diabetes. D'Agord Schaan B; Lacchini S; Bertoluci MC; Irigoyen MC; Machado UF; Schmid H Horm Metab Res; 2001 Nov; 33(11):664-9. PubMed ID: 11733869 [TBL] [Abstract][Full Text] [Related]
12. Chronic salt loading and cardiovascular-associated changes in experimental diabetes in rats. Maeda C; Schaan B; Oliveira E; Oliveira V; De Angelis K; Irigoyen M Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):574-80. PubMed ID: 17581211 [TBL] [Abstract][Full Text] [Related]
13. Antihypertensive and renal-protective effects of losartan in streptozotocin diabetic rats. Kohzuki M; Yasujima M; Kanazawa M; Yoshida K; Fu LP; Obara K; Saito T; Abe K J Hypertens; 1995 Jan; 13(1):97-103. PubMed ID: 7759858 [TBL] [Abstract][Full Text] [Related]
14. Vasopeptidase inhibition prevents target organ damage and improves survival in spontaneously hypertensive rats. Linz W; Schäfer S; Afkham F; Gerl M; Schmidts HL; Rütten H J Renin Angiotensin Aldosterone Syst; 2006 Sep; 7(3):155-61. PubMed ID: 17094052 [TBL] [Abstract][Full Text] [Related]
15. Renin-angiotensin system blockade prevents the increase in plasma transforming growth factor beta 1, and reduces proteinuria and kidney hypertrophy in the streptozotocin-diabetic rat. Erman A; Veksler S; Gafter U; Boner G; Wittenberg C; van Dijk DJ J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):146-51. PubMed ID: 15526251 [TBL] [Abstract][Full Text] [Related]
16. Benazepril, an angiotensin-converting enzyme inhibitor, alleviates renal injury in spontaneously hypertensive rats by inhibiting advanced glycation end-product-mediated pathways. Liu XP; Pang YJ; Zhu WW; Zhao TT; Zheng M; Wang YB; Sun ZJ; Sun SJ Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):287-96. PubMed ID: 19018797 [TBL] [Abstract][Full Text] [Related]
17. Comparison of effects of ACE inhibition with calcium channel blockade on renal disease in a model combining genetic hypertension and diabetes. Rumble JR; Doyle AE; Cooper ME Am J Hypertens; 1995 Jan; 8(1):53-7. PubMed ID: 7734098 [TBL] [Abstract][Full Text] [Related]
18. Meprin-alpha in chronic diabetic nephropathy: interaction with the renin-angiotensin axis. Mathew R; Futterweit S; Valderrama E; Tarectecan AA; Bylander JE; Bond JS; Trachtman H Am J Physiol Renal Physiol; 2005 Oct; 289(4):F911-21. PubMed ID: 15942051 [TBL] [Abstract][Full Text] [Related]
19. Effect of low-dose dual blockade of renin-angiotensin system on urinary TGF-beta in type 2 diabetic patients with advanced kidney disease. Song JH; Cha SH; Lee HJ; Lee SW; Park GH; Lee SW; Kim MJ Nephrol Dial Transplant; 2006 Mar; 21(3):683-9. PubMed ID: 16330466 [TBL] [Abstract][Full Text] [Related]
20. Renal and cardiac effects of antihypertensive treatment with ramipril vs metoprolol in autosomal dominant polycystic kidney disease. Zeltner R; Poliak R; Stiasny B; Schmieder RE; Schulze BD Nephrol Dial Transplant; 2008 Feb; 23(2):573-9. PubMed ID: 17984104 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]